News
Vaccine sales recover at GSK in Q3, but lockdown fears weigh...
GlaxoSmithKline saw a recovery in its vaccine sales in the third quarter after a big hit in the second as a result of the COVID-19 pandemic, putting it back on course to meet the lower end
